The upcoming release of the DSM-5 is criticized for expanding the definition of Autism Spectrum Disorder (ASD) to include a wider range of behaviors. Organizations like "Autism Speaks" and "The Help Group" are scrutinized for their fundraising tactics and ties to the pharmaceutical industry. Diagnostic criteria for infants as young as four months are mocked for pathologizing normal childhood development.
